Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

(211)At is an α-emitter that has similar chemical properties to iodine and is used in targeted α-therapy. In the present study, we added ascorbic acid (AA) to (211)At solution to increase the radiochemical purity of astatide and evaluated its efficacy against differentiated thyroid cancer, which is...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nucl Med
Glavni autori: Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Liu, Yuwei, Shirakami, Yoshifumi, Ooe, Kazuhiro, Toyoshima, Atsushi, Shimosegawa, Eku, Fukuda, Mitsuhiro, Shinohara, Atsushi, Hatazawa, Jun
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2019
Teme:
Theranostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735285/
https://ncbi.nlm.nih.gov/pubmed/30796173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222638
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items